The Paradigm Shift in Health Sciences Literature: Charting the Future of Large Language Models in Scientific Publishing
Abstract
The exponential expansion of biomedical literature, coupled with the growing demand for rapid clinical knowledge dissemination, has created an unsustainably high workload for researchers, peer reviewers, and journal editors. Large Language Models (LLMs) represent a transformative architectural pivot capable of automating, optimizing, and reshaping workflows across the health sciences publishing lifecycle. This paper comprehensively analyzes the current and future applications of LLMs in manuscript preparation, peer review workflows, and editorial curation. Furthermore, we examine the profound technical and ethical vulnerabilities inherent to generative artificial intelligence in medicine—including factual confabulations, demographic biases, and data privacy conflicts with regulatory frameworks like HIPAA and GDPR. Finally, we evaluate the emerging consensus frameworks, such as the FUTURE-AI guidelines and updated International Committee of Medical Journal Editors (ICMJE) criteria, advocating for a hybrid human-AI symbiotic model that preserves scientific integrity while maximizing technological efficacy.
Full Text
The Paradigm Shift in Health Sciences
Literature: Charting the Future of Large
Language Models in Scientific Publishing
AI Author: Gemini, 1.5 Pro.
Developer: Google DeepMind
Role of AI Author: Literature synthesis, structural
organization, and manuscript drafting
Human Prompter: Diego A. Forero, MD, PhD.
School of Health and Sport Sciences, Fundación Universitaria
del Área Andina, Bogotá. Colombia. Email:
dforero41@areandina.edu.co
The exponential expansion of biomedical literature, coupled with the
growing demand for rapid clinical knowledge dissemination, has created
an unsustainably high workload for researchers, peer reviewers, and
journal editors. Large Language Models (LLMs) represent a transformative
architectural pivot capable of automating, optimizing, and reshaping
workflows across the health sciences publishing lifecycle. This paper
comprehensively analyzes the current and future applications of LLMs in
manuscript preparation, peer review workflows, and editorial curation.
Furthermore, we examine the profound technical and ethical
vulnerabilities inherent to generative artificial intelligence in
medicine—including factual confabulations, demographic biases, and data
privacy conflicts with regulatory frameworks like HIPAA and GDPR.
Finally, we evaluate the emerging consensus frameworks, such as the
FUTURE-AI guidelines and updated International Committee of Medical
Journal Editors (ICMJE) criteria, advocating for a hybrid human-AI
symbiotic model that preserves scientific integrity while maximizing
technological efficacy.
Keywords: Large Language Models, Scientific Publishing, Health Sciences,
Peer Review, Publication Ethics, FUTURE-AI, Bioethics.
1. Introduction
Scientific publishing within the health sciences operates under a dual
imperative: it must maintain uncompromising empirical rigor while
accelerating the dissemination of clinical discoveries to optimize
patient care. However, the contemporary biomedical research ecosystem is
facing unprecedented strain. The volume of publications, clinical
trials, and systematic reviews has grown exponentially, outpacing the
capacity of the traditional peer review model and precipitating cognitive
overload among medical professionals (Ahn, 2024; Zhang et al., 2025).
The introduction of transformer-based Large Language Models (LLMs)—
characterized by billions of parameters trained on vast, multimodal text
corpora—has emerged as a disruptive force capable of fundamentally
shifting this paradigm. By analyzing statistical patterns over sequences
of text, LLMs possess an unparalleled capability to comprehend,
summarize, generate, and critique complex scientific prose (Schrager et
al., 2025; Telenti et al., 2024). In the health sciences, where data
modalities extend beyond standard prose to encompass electronic medical
records, genomic sequences, and clinical imagery, LLMs offer a unified
cognitive layer capable of bridging raw laboratory discovery with
polished academic reporting (Telenti et al., 2024).
This paper provides a critical exploration of the future of LLMs within
health sciences academic publishing. It explores how these tools can
democratize scientific communication, outlines the operational risks
they introduce to the scholarly record, and frames the governance
mechanisms necessary to preserve the sanctity of evidence-based
medicine.
2. Applications of LLMs in Medical Manuscript Preparation
The initial phase of the scholarly lifecycle—conceptualization,
literature synthesis, and drafting—is incredibly labor-intensive. LLMs
are rapidly shifting from passive word-processing assistants to
proactive research co-pilots across several operational dimensions.
2.1 Literature Retrieval and Knowledge Synthesis
Traditional database queries often rely heavily on rigid Boolean strings,
which can inadvertently exclude relevant clinical insights due to
semantic variations. LLMs, particularly when paired with semantic search
architectures and Retrieval-Augmented Generation (RAG), allow
researchers to engage in conversational synthesis over vast text
databases (Gencer & Gencer, 2025; Zhang et al., 2025). These systems can
extract granular details from thousands of disparate publications, map
disease-definition variations, and summarize treatment methodologies at
a scale impossible for human investigators acting alone (Gencer & Gencer,
2025).
2.2 Democratizing Global Scientific Communication
A persistent structural inequality in health sciences publishing is the
linguistic barrier faced by non-native English-speaking clinicians and
researchers. Manuscripts containing high-quality clinical data are
frequently rejected by premium journals due to stylistic inconsistencies
or grammatical oversights. LLMs address this disparity by serving as
highly advanced language editors, stylistic calibrators, and real-time
translators (Ahn, 2024). By smoothing syntax, refining vocabulary, and
standardizing structural elements, LLMs allow global researchers to
present their empirical findings equitably, shifting the editorial focus
back to scientific merit rather than linguistic fluency.
2.3 Multimodal Integration and Formatting
The contemporary health sciences landscape requires the synthesis of
heterogeneous data types. Advanced LLMs excel at processing multimodal
inputs, enabling the simultaneous analysis of clinical metadata, protein
sequences, and chemical structures alongside standard textual outputs
(Telenti et al., 2024; Zhang et al., 2025). In manuscript preparation,
these models can automate the creation of data tables, generate baseline
code for statistical validation, and align reference citations with
target journal guidelines, saving significant manual labor (Ahn, 2024).
3. LLMs in the Peer Review and Editorial Ecosystem
The peer review system is facing a systemic bottleneck, driven by a
shortage of qualified human reviewers relative to the sheer volume of
manuscript submissions. LLMs offer a potential solution to this crisis
by streamlining editorial workflows.
3.1 Manuscript Screening and Triage
Upon submission, manuscripts undergo a preliminary editorial screening
to ensure compliance with formatting rules, ethical disclosures, and
core stylistic requirements. Editors are increasingly deploying
specialized LLMs to automate this initial triage phase (Ahn, 2024). These
models can rapidly detect structural errors, identify plagiarism, and
flag basic methodology deficits before human editors review the text.
LLM
Primary Mechanisms /
Major Limitations &
Application
Capabilities
Vulnerabilities
Phase
Language editing,
Reference fabrication,
Pre-
automated translation,
amplification of
Submission /
referencing
underlying author bias,
Writing
alignments, structural
loss of distinct academic
smoothing.
voice.
Automated plagiarism
Editorial
Inability to evaluate deep
checking, format
Screening
intellectual novelty; risk
validation,
LLM
Primary Mechanisms /
Major Limitations &
Application
Capabilities
Vulnerabilities
Phase
methodology
of high false-positive
completeness grading.
rejection rates.
Structural error
"Black box" reasoning,
detection, baseline
Peer Review
systemic leniency (overly
validation check,
Evaluation
positive reviews), data
statistical coding
privacy violations.
replication.
3.2 Automated Reviewer Comments and Hybrid Workflows
Empirical studies demonstrate that LLMs can generate peer review feedback
that significantly overlaps with the comments provided by human experts
(Ahn, 2024). LLMs can identify mathematical discrepancies, flag missing
control groups in clinical designs, and assess the risk of bias within
systematic reviews (Ahn, 2024). However, current iterations demonstrate
distinct behavioral biases. For instance, LLMs frequently generate
overly positive evaluations and lack the deep domain experience required
to gauge the conceptual novelty or potential real-world clinical impact
of a study (Ahn, 2024).
Consequently, the future of peer review is not fully autonomous, but
rather a hybrid framework. In this model, AI tools handle lower-order
reviewing duties—such as proofreading, compliance checks, and structural
verification—allowing human experts to focus on higher-order evaluative
tasks like conceptual validity, ethical feasibility, and clinical
clinical relevance (Ahn, 2024).
4. Ethical, Technical, and Legal Vulnerabilities
While the benefits of LLMs are substantial, their integration into health
sciences publishing introduces complex risks. Because medical research
directly influences clinical behavior and patient outcomes, errors
within published medical literature can have serious, real-world safety
implications.
4.1 Factual Confabulations and Hallucinations
A core characteristic of LLMs is their probabilistic nature; they
generate sequences of text based on statistical likelihood rather than
an underlying understanding of absolute factual truth (Schrager et al.,
2025). This architectural trait leads to "hallucinations"—the generation
of highly plausible but entirely fabricated information (Ahn, 2024;
Schrager et al., 2025). In medical writing, this can manifest as fake
patient data, fabricated biochemical interactions, or entirely invented
journal references (Ahn, 2024).
Even advanced multimodal models, such as GPT-4V, exhibit this
vulnerability. When evaluated on clinical image challenges, these models
may identify the correct diagnosis while providing deeply flawed or
entirely fabricated rationales for their choice (Ahn, 2024). The
dissemination of such errors within the peer-reviewed record poses a
direct risk to clinical safety.
4.2 The "Paywall Blind Spot" and Information Bias
The empirical reliability of an LLM is inherently restricted by the scope
and quality of its training data. A significant limitation for academic
publishing tools is the "paywall blind spot." While public open-access
repositories like PubMed Central and arXiv are widely represented in
major training datasets, premium subscription content from major
publishers (e.g., Elsevier, Springer Nature, Wiley) is often blocked by
authentication barriers (Ahn, 2024).
As a result, LLMs are frequently trained on text-scraped data where open-
access publications are overrepresented, while paywalled, high-impact
clinical trials and rigorous methodological breakdowns are
underrepresented. This creates a systemic information bias. Authors
relying solely on LLMs for literature synthesis risk missing critical,
paywalled methodological details, which can compromise the
comprehensiveness of their research.
4.3 Demographic Bias Preservation
LLMs tend to mirror and amplify the systematic demographic biases present
within their training data. In the medical domain, this risk is
particularly acute, as models can propagate outdated, race-based medical
assumptions, false characterizations of pain thresholds, or biased
diagnostic metrics across diverse populations (Ahn, 2024). If authors
rely uncritically on LLMs to draft clinical discussions or synthesize
public health strategies, they risk institutionalizing these demographic
biases within the peer-reviewed literature, potentially exacerbating
health disparities.
4.4 Data Privacy, Confidentiality, and Regulatory Compliance
The peer review process is built on strict confidentiality. When a
reviewer uploads an unpublished manuscript into a commercial, cloud-
hosted LLM platform to generate summary text or feedback, that
intellectual property may be ingested to train future iterations of the
model (Ahn, 2024). This constitutes a serious breach of confidentiality
and a violation of intellectual property rights (Ahn, 2024).
Furthermore, integrating clinical data or unstructured electronic health
records into external generative AI platforms raises significant legal
issues under privacy frameworks like HIPAA and GDPR (Ahn, 2024).
Developing secure, locally deployed, open-source LLM workflows that
comply with these strict regulatory frameworks remains a significant
technical challenge for research institutions (Ahn, 2024).
5. Policy Frameworks and Consensus Guidelines
To safeguard the scientific record, publishers, editorial associations,
and international AI consortia have established strict ethical
guidelines governing the deployment of generative AI.
5.1 Authorship and Accountability Denials
The consensus across leading editorial bodies—including the Committee on
Publication Ethics (COPE), the World Association of Medical Editors
(WAME), and the International Committee of Medical Journal Editors
(ICMJE)—is unambiguous: Large Language Models cannot be listed as authors
on scientific publications (Ahn, 2024).
Authorship carries strict intellectual accountability for the accuracy,
integrity, and ethical compliance of the work. Because AI tools cannot
take legal or moral responsibility for their outputs, they do not satisfy
these criteria (Ahn, 2024).
ICMJE Core Principle Summary: Authors bear full, unshared responsibility
for verifying all content generated or assisted by artificial
intelligence tools. Any inclusion of erroneous data or fabricated
references constitutes scientific misconduct on the part of the human
authors (Ahn, 2024; Ganjavi et al., 2024).
5.2 Mandatory Disclosure and Transparency Metrics
Current editorial standards require complete transparency regarding AI
usage. Under modern guidelines, such as those adopted by the Annals of
Geriatric Medicine and Research, authors must declare the deployment of
generative AI tools both within their cover letters and in a dedicated
section of the manuscript, specifying the exact model name, version
number, manufacturer, and scope of application (Ahn, 2024). While routine
language editing or spell-checking typically does not require formal
disclosure, any substantive contribution to data analysis, literature
synthesis, or text generation must be explicitly detailed (Ahn, 2024).
5.3 The FUTURE-AI Consortium Framework
To move beyond ad-hoc journal policies, the international FUTURE-AI
Consortium established a cohesive, multi-disciplinary framework for the
responsible deployment of AI in health sciences (Lekadir et al., 2025).
The guideline is organized around six core principles:
1. Fairness: Ensuring AI tools perform consistently across diverse
demographic subgroups, actively identifying and minimizing
underlying training bias (Lekadir et al., 2025).
2. Universality: Standardizing models to ensure operational utility
across varying clinical environments and technical infrastructures
(Lekadir et al., 2025).
3. Traceability: Documenting the entire lifecycle of the AI tool—
including data curation, exact prompt structures, optimization
details, and stochasticity handling (Lekadir et al., 2025).
4. Usability: Ensuring human-centric designs that allow clinicians
and reviewers to interpret outputs easily without excessive
technical training (Lekadir et al., 2025).
5. Robustness: Validating models against unexpected data shifts,
technical variations, and adversarial inputs to prevent clinical
errors (Lekadir et al., 2025).
6. Explainability: Developing interpretable models that explicitly
detail the clinical or statistical rationale behind an output,
moving away from uninterpretable "black box" systems (Lekadir et
al., 2025).
6. Future Horizons: The Next Decade of AI-Symbiotic Publishing
Looking toward the next decade, the role of LLMs in health sciences
publishing will likely transition from basic assistive automation to a
fully integrated, collaborative workflow.
6.1 Real-Time Peer Review and Dynamic Updating
The traditional, static "publish-and-forget" format of medical journals
is increasingly out of step with the rapid pace of clinical data
generation. Future publishing paradigms may leverage specialized,
locally hosted medical LLMs to provide continuous, real-time post-
publication peer review. As new clinical trials or epidemiological data
emerge, automated AI systems could screen existing publications,
dynamically updating systematic reviews, meta-analyses, and clinical
guidelines while highlighting contradictions or confirming medical
hypotheses as new evidence accumulates.
6.2 Shift in Academic Valuations and the "Human Core"
As LLMs become highly proficient at generating grammatically pristine,
stylistically polished scientific prose, the historical correlation
between fluid writing and high-quality science will decouple (Ahn, 2024).
Editorial boards and peer reviewers will adapt by placing less emphasis
on prose mechanics, focusing instead on the core human elements of
research: the prospective design of clinical trials, the execution of
laboratory experiments, ethical oversight, and the nuanced
interpretation of anomalous results (Ahn, 2024). The value of a
scientific manuscript will reside in its empirical integrity and
conceptual novelty, rather than its stylistic execution.
7. Conclusion
Large Language Models present a powerful opportunity to optimize health
sciences publishing, offering tools to mitigate reviewer burnout,
democratize global scientific writing, and synthesize vast amounts of
clinical data. However, their integration introduces significant risks
to scientific integrity, including factual hallucinations, data privacy
vulnerabilities, and demographic biases.
To navigate this transition safely, the medical research community must
reject both uncritical adoption and outright resistance. The future of
health sciences publishing lies in a collaborative, human-AI symbiotic
workflow. By establishing rigorous governance frameworks—such as the
FUTURE-AI guidelines—and maintaining absolute human accountability for
the verification of empirical data, the scientific community can leverage
generative AI to accelerate discovery while safeguarding the evidence-
based foundation of clinical medicine.
References
• Ahn, S. (2024). The transformative impact of large language models on medical writing and publishing: current applications, challenges and future directions. The Korean Journal of Physiology & Pharmacology, 28(5), 393–401. https://doi.org/10.4196/kjpp.2024.28.5.393 • Ganjavi, C., Eppler, M B., Pekcan, A., Biedermann, B., Abreu, A., Collins, G. S., Gill, I. S., & Cacciamani, G. E. (2024). Publishers’ and journals’ instructions to authors on use of generative artificial intelligence in academic and scientific publishing: bibliometric analysis. BMJ, 384, e077192. https://doi.org/10.1136/bmj-2023-077192 • Gencer, G., & Gencer, K. (2025). Large Language Models in Healthcare: A Bibliometric Analysis and Examination of Research Trends. Journal of Multidisciplinary Healthcare, Volume 18, 223–238. https://doi.org/10.2147/jmdh.s502351 • Lekadir, K., Frangi, A. F., Porras, A. R., Glocker, B., Cintas, C., Langlotz, C. P., Weicken, E., Asselbergs, F. W., Prior, F., Collins, G. S., Kaissis, G., Tsakou, G., Buvat, I., Kalpathy-Cramer, J., Mongan, J., Schnabel, J. A., Kushibar, K., Riklund, K., Marias, K., Amugongo, L. M., Fromont, L. A., Maier-Hein, L., Cerdá-Alberich, L., Martí-Bonmatí, L., & Cardoso, M. J. (2025). FUTURE-AI: international consensus guideline for trustworthy and deployable artificial intelligence in healthcare. BMJ, e081554. https://doi.org/10.1136/bmj-2024-081554 • Schrager, S., Seehusen, D. A., Sexton, S., Richardson, C. R., Neher, J., Pimlott, N., Bowman, M. A., Rodríguez, J., Morley, C. P., Li, L., & Dera, J. D. (2025). Use of AI in Family Medicine Publications: A Joint Editorial From Journal Editors. The Annals of Family Medicine, 23(1), 1–4. https://doi.org/10.1370/afm.240575 • Telenti, A., Auli, M., Hie, B. L., Maher, C., Saria, S., & Ioannidis, J. P. A. (2024). Large language models for science and medicine. European Journal of Clinical Investigation, 54(1). https://doi.org/10.1111/eci.14183 • Zhang, K., Meng, X., Yan, X., Ji, J., Liu, J., Xu, H., Zhang, H., Liu, D., Wang, J., Wang, X., Gao, J., Wang, Y., Shao, C., Wang, W., Li, J., Zheng, M., Yang, Y., & Tang, Y. (2025). Revolutionizing Health Care: The Transformative Impact of Large Language Models in Medicine. Journal of Medical Internet Research, 27, e59069. https://doi.org/10.2196/59069
📝 About this HTML version
This HTML document was automatically generated from the PDF. Some formatting, figures, or mathematical notation may not be perfectly preserved. For the authoritative version, please refer to the PDF.